News

Media

Conferences

Publications

Clinical

Events

CME/CE

Resources

Andrew Skinner, MD

home / authors / andrew-skinner-md

Articles

Key Takeaways on FMTs in the Treatment of CDI

Stuart Johnson, MD;Joseph Reilly, BS, PharmD, BCGP;Candace Cotto, RN;Andrew Skinner, MD

June 9th 2023

Experts provide practice pearls for educating patients on and using FMTs for the management of CDI.

Economic Implications of FMTs on CDI

Stuart Johnson, MD;Joseph Reilly, BS, PharmD, BCGP;Candace Cotto, RN;Andrew Skinner, MD

June 9th 2023

Joseph Reilly, BS, PharmD, BCGP, reviews the positive economic impact of use of live-jslm for treatment of CDI in a hospital setting.

Preventing the Spread of CDI in the Healthcare Setting

Stuart Johnson, MD;Joseph Reilly, BS, PharmD, BCGP;Candace Cotto, RN;Andrew Skinner, MD

June 9th 2023

Experts comment on the measures that need to be taken to prevent or control the spread of CDI in the healthcare setting.

Clinician and Patient Education on FMT in CDI

Stuart Johnson, MD;Joseph Reilly, BS, PharmD, BCGP;Candace Cotto, RN;Andrew Skinner, MD

June 2nd 2023

Candace Cotto, RN, and Andrew Skinner, MD, discuss barriers to use of FMTs in managing CDI, highlighting clinician and patient education.

Insurance Coverage of FMTs in CDI

Stuart Johnson, MD;Joseph Reilly, BS, PharmD, BCGP;Candace Cotto, RN;Andrew Skinner, MD

June 2nd 2023

Experts comment on insurance coverage as a factor for the broader use of FMTs for the management of CDI.

Incorporating FMT Treatment Into Clinical Practice

Stuart Johnson, MD;Joseph Reilly, BS, PharmD, BCGP;Candace Cotto, RN;Andrew Skinner, MD

May 26th 2023

Candace Cotto, RN, reviews the process of incorporating fecal microbiota, live-jslm treatment into clinical practice, what patients can expect, and the room sanitation process after the procedure.

Advances in the CDI Treatment Landscape

Stuart Johnson, MD;Joseph Reilly, BS, PharmD, BCGP;Candace Cotto, RN;Andrew Skinner, MD

May 26th 2023

Experts discuss new and emerging treatments the management of CDI, highlighting the phase 3 trials for SER 109.

Role of Live-JSLM in Treating Recurrent CDI

Stuart Johnson, MD;Timothy Reilly, PharmD, BCPS, CGP, FASCP;Candace Cotto, RN;Andrew Skinner, MD

May 19th 2023

Joseph Reilly, BS, PharmD, BCGP, and Andrew Skinner, MD, discuss the potential benefits of using live-jslm early on to treat CDI, as well as the implications of this new treatment.

Use of Live-JSLM in the Treatment of CDI

Stuart Johnson, MD;Joseph Reilly, BS, PharmD, BCGP;Candace Cotto, RN;Andrew Skinner, MD

May 19th 2023

Joseph Reilly, BS, PharmD, BCGP, provides an overview of a new FDA-approved FMT therapy, live-jslm for the treatment of CDI.

Use of Fecal Microbiota Transplantation (FMT) Treatment in CDI

Stuart Johnson, MD;Joseph Reilly, BS, PharmD, BCGP;Candace Cotto, RN;Andrew Skinner, MD

May 12th 2023

Candace Cotto, RN, and Andrew Skinner, MD, discuss the challenges of traditional fecal microbiota transplantation (FMT) in treatment of CDI.

Challenges in the Management of CDI

Stuart Johnson, MD;Joseph Reilly, BS, PharmD, BCGP;Candace Cotto, RN;Andrew Skinner, MD

May 12th 2023

Andrew Skinner, MD, reviews challenges in managing CDI, as well as the treatment guidelines from IDSA, SHEA, and ACG.

Diagnosis of C difficile Infection (CDI)

Stuart Johnson, MD;Joseph Reilly, BS, PharmD, BCGP;Candace Cotto, RN;Andrew Skinner, MD

May 5th 2023

Joseph Reilly, BS, PharmD, BCGP; Candace Cotto, RN; and Andrew Skinner, MD, review C. difficile infection (CDI), its risk factors, symptoms, and quality of life for the patient.

Overview of Gut Microbiome

Stuart Johnson, MD;Joseph Reilly, BS, PharmD, BCGP;Candace Cotto, RN;Andrew Skinner, MD

May 5th 2023

Experts provide an overview of the gut microbiome and its importance to nutrition and overall health.